Not logged in Share Save
Share Save
Share Save
Share Save
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis Legat, Franz J.; Kwatra, Shawn G.; Reich, Adam; Boulinguez, Serge; Tsianakas, Athanasios; Sauder, Maxwell; Barbarot, Sebastien; Szepietowski, Jacek C.; Conrad, Curdin; Pink, Andrew E.; Weisshaar, Elke; Misery, Laurent; Metz, Martin; Laquer, Vivian T.; Sivamani, Raja K.; Yosipovitch, Gil; Thaci, Diamant; Skov, Lone; Chen, Xiaoxiao; Noda, Aliene; Jabbar-Lopez, Zarif K.; Piketty, Christophe; Stander, Sonja Share Save
Share Save
Share Save
Share Save
Share Save
Nemolizumab elicits rapid itch-free state and sleep improvement in prurigo nodularis Pink, Andrew E.; Silverberg, Jonathan, I; Staender, Sonja; Elmariah, Sarina; Yosipovitch, Gil; Metz, Martin; Legat, Franz J.; Sauder, Maxwell; Kim, Brian; da Silva Santos, Carla S.; Chen, Xiaoxiao; Jabbar-Lopez, Zarif; Noda, Aliene; Piketty, Christophe; Kwatra, Shawn G. Share Save
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents A Phase 3 Randomized Clinical Trial Zhao, Yan; Gooderham, Melinda; Yang, Bin; Wu, Jiyuan; Wu, Liming; Loo, Wei Jing; Toth, Darryl; Sauder, Maxwell; Li, Jingyi; Chen, Aijun; Tao, Xiaohua; Lu, Jianyun; Song, Zhiqiang; Han, Jiande; Li, Hongyi; Li, Yijing; Xu, Lihong Share Save
Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patients Genta, S.; Araujo, D., V; Hueniken, K.; Pipinikas, C.; Ventura, R.; Rojas, P.; Jones, G.; Butler, M. O.; Saibil, S. D.; Yu, C.; Easson, A.; Covelli, A.; Sauder, M. B.; Fournier, C.; Kamil, Z. Saeed; Rogalla, P.; Arteaga, D. P.; Vornicova, O.; Spiliopoulou, P.; Muniz, T. P.; Siu, L. L.; Spreafico, A. Share Save
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process Apalla, Z.; Freites-Martinez, A.; Grafanaki, K.; Ortiz-Brugues, A.; Nikolaou, V.; Fattore, D.; Sollena, P.; Deverapalli, S.; Babakoohi, S.; Galimont, A.; Kluger, N.; Beylot-Barry, M.; Larocca, C.; Iriarte, C.; Smith, J.; Tattersall, I.; Dodiuk-Gad, R.; Sauder, M.; Carrera, C.; Kwong, B.; Whitley, M.; Leboeuf, N.; Romano, P.; Starace, M.; Mateeva, V.; Riganti, J.; Hirner, J.; Patel, A. B.; Reyes-Habito, C. M.; Kraehenbuehl, L.; Kheterpal, M.; Fida, M.; Hassel, J.; Lacouture, M.; Sibaud, V. Share Save
A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis Gooderham, Melinda; Lynde, Charles; Alam, Maryam Shayesteh; Sadick, Neil; Rohan, Craig A.; Werschler, William Philip; Hebert, Adelaide A.; Laquer, Vivian T.; Sauder, Maxwell; Del Rosso, James Q.; Rodgers, Timothy; Tan, Ricardo; Schleicher, Stephen; Murrell, Dedee F.; Fernandez-Penas, Pablo; Reich, Adam; Gkalpakiotis, Spyridon; Ruiz, Juan Ruano; Wollenberg, Andreas; Szepietowski, Jacek C.; Sticherling, Michael; Weyergraf, Ansgar J.; Hadzavdic, Suzana Ljubojevic; Baran, Wojciech; Vilchez, Trinidad Montero; Eniko, Telegdy; Sebastian, Michael; Chaudhry, Sohail; Lee, Zachary; Yu, Danni; Liu, Yi; Waltz, Wang; Gilbert, Jenny; Elko-Simms, Lucinda M.; Fanton, Christie; Jue, Charleen; Tagliaferri, Mary; Zalevsky, Jonathan; Rosmarin, David Share Save
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials Silverberg, Jonathan, I; Wollenberg, Andreas; Reich, Adam; Thaci, Diamant; Legat, Franz J.; Papp, Kim A.; Gold, Linda Stein; Bouaziz, Jean-David; Pink, Andrew E.; Carrascosa, Jose Manuel; Rewerska, Barbara; Szepietowski, Jacek C.; Krasowska, Dorota; Havlickova, Blanka; Kalowska, Monika; Magnolo, Nina; Pauser, Sylvia; Nami, Navid; Sauder, Maxwell B.; Jain, Vipul; Padlewska, Kamila; Cheong, Soo Yeon; Morel, Patricia Fleuranceau; Ulianov, Liliana; Piketty, Christophe Share Save
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis Kwatra, S. G.; Yosipovitch, G.; Legat, F. J.; Reich, A.; Paul, C.; Simon, D.; Naldi, L.; Lynde, C.; De Bruin-Weller, M. S.; Nahm, W. K.; Sauder, M.; Gharib, R.; Barbarot, S.; Szepietowski, J. C.; Conrad, C.; Fleischer, A.; Laquer, V. T.; Misery, L.; Serra-Baldrich, E.; Lapeere, H.; Ahmad, F.; Lopez, Z. K. Jabbar; Piketty, C.; Staender, S. Share Save
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT) Genta, Sofia; Lajkosz, Katherine; Yee, Noelle R.; Spiliopoulou, Pavlina; Heirali, Alya; Hansen, Aaron R.; Siu, Lillian L.; Saibil, Sam; Stayner, Lee-Anne; Yanekina, Maryia; Sauder, Maxwell B.; Keshavarzi, Sareh; Salawu, Abdulazeez; Vornicova, Olga; Butler, Marcus O.; Bedard, Philippe L.; Razak, Albiruni R. Abdul; Rottapel, Robert; Chruscinski, Andrzej; Coburn, Bryan; Spreafico, Anna Share Save
Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management Mital, Rohan; Otto, Tracey S.; Savu, Andrei; Baumrin, Emily; Cardones, Adela R.; Carlesimo, Marta; Caro, Gemma; Freites-Martinez, Azael; Hirner, Jesse P.; Markova, Alina; McLellan, Beth N.; Rossi, Alfredo; Sauder, Maxwell B.; Seminario-Vidal, Lucia; Sibaud, Vincent; Owen, Dwight H.; Dulmage, Brittany O.; Chen, Steven T.; Kaffenberger, Benjamin H. Share Save
Share Save
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway Loo, Wei Jing; Turchin, Irina; Prajapati, Vimal H.; Gooderham, Melinda J.; Grewal, Parbeer; Hong, Chih-ho; Sauder, Maxwell; Vender, Ronald B.; Maari, Catherine; Papp, Kim A. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
